biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study✦05:34 AI readings of heart MRIs slightly beat doctors at flagging death risk✦05:35 Drugmaker asks FDA to test a new shot for advanced dry macular degeneration✦23:41 Top OB-GYN group updates hot-flash advice for first time in 12 years✦23:39 Blood proteins tied to menopause may hint at women's later dementia risk✦23:36 Earlier heart valve fix cut heart failure events in some older adults✦23:35 FDA sets May 2027 decision date for one-time Huntington's gene therapy✦17:48 Women reported less brain fog on a supplement in a study with no placebo✦05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study✦05:34 AI readings of heart MRIs slightly beat doctors at flagging death risk✦05:35 Drugmaker asks FDA to test a new shot for advanced dry macular degeneration✦23:41 Top OB-GYN group updates hot-flash advice for first time in 12 years✦23:39 Blood proteins tied to menopause may hint at women's later dementia risk✦23:36 Earlier heart valve fix cut heart failure events in some older adults✦23:35 FDA sets May 2027 decision date for one-time Huntington's gene therapy✦17:48 Women reported less brain fog on a supplement in a study with no placebo
← All story threadsSTORY THREAD

OliX's eye shot for advanced dry macular degeneration.

1 report so far. New developments are added to this thread as they happen.

  1. Nov 2, 2026
    COMPANY ASKS FDA TO START A US TRIALTrial request to FDA

    Drugmaker asks FDA to test a new shot for advanced dry macular degeneration

    South Korea's OliX filed to start a 64-person US trial of an eye injection that aims to switch off an inflammation signal behind geographic atrophy, a form of dry macular degeneration that steals central vision.